Arrowhead Pharmaceuticals, Inc. (ARWR)
58.50
+0.12
(+0.21%)
USD |
NASDAQ |
Oct 15, 16:00
59.20
+0.70
(+1.21%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Cash from Operations (TTM) : -59.06M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -59.06M |
| March 31, 2026 | -31.31M |
| December 31, 2025 | 344.30M |
| September 30, 2025 | 179.55M |
| June 30, 2025 | 21.84M |
| March 31, 2025 | 56.15M |
| December 31, 2024 | -496.28M |
| September 30, 2024 | -462.85M |
| June 30, 2024 | -350.89M |
| March 31, 2024 | -256.92M |
| December 31, 2023 | -196.21M |
| September 30, 2023 | -153.89M |
| June 30, 2023 | -197.30M |
| March 31, 2023 | -244.70M |
| December 31, 2022 | -150.30M |
| September 30, 2022 | -136.13M |
| June 30, 2022 | -91.58M |
| March 31, 2022 | -52.34M |
| December 31, 2021 | 148.80M |
| September 30, 2021 | 171.22M |
| June 30, 2021 | 184.49M |
| March 31, 2021 | 180.67M |
| December 31, 2020 | -110.78M |
| September 30, 2020 | -95.39M |
| June 30, 2020 | -70.73M |
| Date | Value |
|---|---|
| March 31, 2020 | -26.78M |
| December 31, 2019 | -18.78M |
| September 30, 2019 | 173.03M |
| June 30, 2019 | 156.54M |
| March 31, 2019 | 131.61M |
| December 31, 2018 | 135.75M |
| September 30, 2018 | -47.22M |
| June 30, 2018 | -53.75M |
| March 31, 2018 | -49.75M |
| December 31, 2017 | -48.63M |
| September 30, 2017 | -23.94M |
| June 30, 2017 | -24.92M |
| March 31, 2017 | -32.86M |
| December 31, 2016 | -33.28M |
| September 30, 2016 | -64.43M |
| June 30, 2016 | -66.27M |
| March 31, 2016 | -61.03M |
| December 31, 2015 | -62.66M |
| September 30, 2015 | -65.71M |
| June 30, 2015 | -64.61M |
| March 31, 2015 | -61.27M |
| December 31, 2014 | -52.59M |
| September 30, 2014 | -35.42M |
| June 30, 2014 | -29.89M |
| March 31, 2014 | -25.45M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Moderna, Inc. | -1.073B |
| Sarepta Therapeutics, Inc. | 93.95M |
| Revolution Medicines, Inc. | -1.223B |
| Intellia Therapeutics, Inc. | -346.64M |
| Denali Therapeutics, Inc. | -434.04M |